BNP Paribas Asset Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.6K Buy
2,385
+2
+0.1% +$9 ﹤0.01% 2145
2026
Q1
$9.22K Buy
2,383
+411
+21% +$1.69K ﹤0.01% 2235
2025
Q4
$8K Buy
+1,972
New +$7.63K ﹤0.01% 2225

Other funds holding PGEN

BNP Paribas Asset Management's PGEN Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Precigen (PGEN) stake by 0.08% in Q2 2026, buying an estimated $9 and bringing the position to 2,385 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2145.

BNP Paribas Asset Management first reported a position in PGEN in Q4 2025 and has held it in 3 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • BNP Paribas Asset Management held 2,385 shares of Precigen worth $13.6K as of Q2 2026.
  • BNP Paribas Asset Management bought 2 Precigen shares in Q2 2026, an estimated $9.
  • Precigen made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2145 holding.
  • BNP Paribas Asset Management first reported a position in Precigen in Q4 2025 and has held it in 3 quarters since.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.